Tuesday, February 28, 2012

Johnson & Johnson: $JNJ Cash Flow Update


Current Price: ~ $65/share
Projected Yield: ~ 3.54%



Johnson & Johnson ranks as the world's largest and most diverse health-care company. The company comprises three divisions: pharmaceutical, medical devices and diagnostics, and consumer. While the pharmaceutical division currently represents close to 36% of total sales, we expect patent losses and the Synthes acquisition to reduce this proportion to approximately 27% during the next 10 years, with the device segment picking up the majority of the share.           


Estimated WACC for the firm today is 7.16% using the Capital Asset Pricing Model and the company's recent SEC filings.

Recent free cash flows and noted growth rates:

Year
FCF $Millions
2002
6077
2003
8333
2004
8956
2005
9245
2006
11510
2007
11939
2008
11906
2009
14206
2010
14001
2011
11405


Average Annual Growth FCF: ~ 8%
CAGR FCF: ~ 7%
Consensus Forecast Industry 5-Year Growth: ~ 7% per year
Consensus Forecast Company 5-Year Growth: ~ 6% per year
Internal Growth Rate: ~ 3%
Sustainable Growth Rate: ~ 6%

Scenario 1
Average FCF (2011, 2010) is $12703 million
  • Start at $12703 million FCF
  • Assume a 5-year growth rate in FCF of 6% per year, then no growth or 0% growth in FCF per year forever:

Discounted Cash Flow Valuation

Year
FCF $Millions
0
12703
1
13465
2
14273
3
15129
4
16037
5
16999
Terminal Value
251581



The firm's future cash flows, discounted at a WACC of 7.16%, give a present value for the entire firm (Debt + Equity) of $239496 million. If the firm's fair value of debt is estimated at $15585 million, then the fair value of the firm's equity could be $223911 million.  $223911 million / 2750 million outstanding shares is approximately $81 per share and a 20% margin of safety is $65/share.

Scenario 2
All else being equal,
  • Assume a 5-year growth rate in FCF of 2% per year, then 0% growth in FCF per year forever:

Discounted Cash Flow Valuation

Year
FCF $Millions
0
12703
1
12957
2
13216
3
13481
4
13750
5
14025
Terminal Value
199730


  • Present Value of the entire firm (Debt + Equity): $196233 million
  • Value of Equity: $180648 million or $66/share
  • 20% margin of safety is $53/share



Sources
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

No comments:

Post a Comment